Curious to know more about the #Netflix model for antimicrobials? The SMASH study in the UK explored the views of infection consultants in England on the novel antimicrobial subscription model for #cefiderocol and #ceftazidime-avibactam that started in July 2022. Are delinked funding models the solution to the dry antimicrobial production pipeline?
https://doi.org/10.1093/jacamr/dlad091
#JACAMRNews